92
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Formulation of venlafaxine for once daily administration using polymeric material hybrids

&
Pages 299-306 | Received 27 Oct 2015, Accepted 11 Apr 2016, Published online: 27 Apr 2016

References

  • Aboelwafa AA, Basalious EB. Optimization and in vivo pharmacokinetic study of a novel controlled release venlafaxine hydrochloride three-layer tablet. AAPS PharmSciTech, 2010;11(3):1026–37.
  • Balas F, Manzano M, Horcajada P, Vallet-Regí M. Confinement and controlled release of bisphosphonates on ordered mesoporous silica-based materials. J Am Chem Soc, 2006;128(25):8116–17.
  • Bordeleau L, Pritchard KI, Loprinzi CL, Ennis M, Jugovic O, Warr D, Haq R, Goodwin PJ. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol, 2010;28(35):5147–52.
  • Borodkin S, Yunker MH. Interaction of amine drugs with a polycarboxylic acid ion-exchange resin. J Pharm Sci, 1970;59:481–6.
  • Boyd GE, Adamson AW, Myers JR. The exchange adsorption of ions from aqueous solutions by organic zeolites. II. Kinetics. J Am Chem Soc, 1947;69:2836–48.
  • Cuňa M, Vila Jato JL, Torres D. Controlled-release liquid suspensions based on ion-exchange particles entrapped within acrylic microcapsules. Int J Pharm, 2000;199:151–8.
  • Cunningham LA. Once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression. Venlafaxine XR 208 study group. Ann Ann Clin Psychiatry, 1997;9(3):157–64.
  • Derringer G, Suich R. Simultaneous optimization of several responses variables. J Qual Technol, 1980;12(4):214–19.
  • Dierick M. A review of the efficacy and tolerability of venlafaxine. Eur Psychiatry, 1997;12(Suppl 4):307s–13s.
  • Einarson TR, Arikian S, Casciano J, Doyle J. Comparison of extended-release venlafaxine, selective serotonin reuptake inhibitors, and tricyclic antidepressants in the treatment of depression: A meta-analysis of randomized controlled trials. Clin Ther, 1999;21(2):296–303.
  • Einarson TR, Arikian S, Sweeney S, Doyle J. A model to evaluate the cost effectiveness of oral therapies in the management of patients with major depressive disorders. Clin Ther, 1995;17(1):136–53.
  • Halder A, Sa B. preparation and in vitro evaluation of polystyrene-coated diltiazem-resin complex by oil-in-water emulsion solvent evaporation method. AAPS PharmSciTech, 2006;7(2):E105–12.
  • Hussein A, Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim NM. Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposites. Int J Nanomedicine, 2012;7:2129–41.
  • Irwin WJ, Belaid KA, Alpar HO. Drug-delivery by ion-exchange: Part III. Interaction of ester pro-drugs of propranolol with cationic exchange resins. Drug Dev Ind Pharm, 1987;13(9–11):2047–66.
  • Jeong SH, Park K. Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix. Int J Pharm, 2008;361:26–32.
  • Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry, 1994;164(5):665–73.
  • Lai CY, Trewyn BG, Jeftinija DM, Jeftinija K, Xu S, Jeftinija S, Lin VS. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules. J Am Chem Soc, 2002;125:4451–9.
  • Linder WD, Lippold BC. Drug release from hydrocolloid embeddings with high or low susceptibility to hydrodynamic stress. Pharm Res, 1995;12(11):1781–5.
  • Liu J, Liu F, Gao K, Wu J, Xue D. Recent developments in the chemical synthesis of inorganic porous capsules. J Mater Chem, 2009;19:6073–84.
  • Liu Y, Sun Y, Sun J, Zhao N, Sun M, He Z. Preparation and in vitro/in vivo evaluation of sustained-release venlafaxine hydrochloride pellets. Int J Pharm, 2012;426(1–2):21–8.
  • Madani SY, Naderi N, Dissanayake O, Tan A, Seifalian AM. A new era of cancer treatment: Carbon nanotubes as drug delivery tools. Int J Nanomedicine, 2011;6:2963–79.
  • Makhija SN, Vavia PR. Once daily sustained release tablets of venlafaxine, a novel antidepressant. Eur J Pharm Biopharm, 2002;54(1):9–15.
  • Mandrioli R, Mercolini L, Cesta R, Fanali S, Amore M, Raggi MA. Analysis of the second generation antidepressant venlafaxine and its main active metabolite O-desmethyl venlafaxine in human plasma by HPLC with spectrofluorimetric detection. J Chromatogr B Analyt Technol Biomed Life Sci, 2007;856(1–2):88–94.
  • Modi A, Tayade P. Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS PharmSciTech, 2006;7(3):E87–92.
  • Nelder JA, Mead R. A simple method for function minimization. Comput J, 1965;7(4):308–13.
  • Patel HA, Shah S, Shah DO, Joshi PA. Sustained release of venlafaxine from venlafaxine–montmorillonite–polyvinylpyrrolidone composites. Appl Clay Sci, 2011;51(1-2):126–30.
  • Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv, 1985;60(4):110–11.
  • Pongjanyakul T, Prakongpan S, Rungsardthong U, Chancham P, Priprem A. Characteristics and in vitro release of dextromethorphan resinates. Powder Technol. 2005;152:100–106.
  • Raghunathan Y, Amsel L, Hinsvark O, Bryant W. Sustained-release drug delivery system I: Coated ion-exchange resin system for phenylpropanolamine and other drugs. J Pharm Sci, 1981;70(4):379–84.
  • Ravi S, Peh KK, Darwis Y, Murthy BK, Singh TR, Mallikarjun C. Development and characterization of polymeric microspheres for controlled release protein loaded drug delivery system. Indian J Pharm Sci, 2008;70(3):303–9.
  • Reichenberg D. Properties of ion-exchange resins in relation to their structure. Part III. Kinetics of exchange. J Am Chem Soc, 1953;75:589–97.
  • Shamma RN, Basalious EB, Shoukri RA. Development and optimization of a multiple-unit controlled release formulation of a freely water soluble drug for once-daily administration. Int J Pharm, 2011;405(1–2):102–12.
  • Shao N, Su Y, Hu J, Zhang J, Zhang H, Cheng Y. Comparison of 3 generation polyamidoamine dendrimer and generation 4 polypropylene imine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity. Int J Nanomedicine, 2011;6:3361–72.
  • Tang J, Slowing I, Huang Y, Trewyn BG, Hu J, Liu H, Lin VS. Poly(lactic acid)-coated mesoporous silica nanosphere for controlled release of Venlafaxine. J Colloid Interface Sci, 2011;360(2):488–96.
  • Torres D, Boado L, Blanco L, Vila-Jato JL. Comparison between aqueous and non-aqueous solvent evaporation methods for microencapsulation of drug–resin complexes. Int J Pharm, 1998;173:171–82.
  • Wu X, Tan Y, Mao H, Zhang M. Toxic effects of iron oxide nanoparticles on human umbilical vein endothelial cells. Int J Nanomedicine, 2010;5:385–99.
  • Yang JH, Han YS, Park M, Park T, Hwang SJ, Choy JH. New inorganic-based drug delivery system of indole-3-acetic acid-layered metal hydroxide nanohybrids with controlled release rate. Chem Mater, 2007;19(10):2679–85.
  • Zuo J, Gao Y, Bou-Chacra N, Löbenberg R. Evaluation of the DDSolver software applications. BioMed Res Int, 2014; 2014:204925–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.